South Africa
Primary tabs
South Africa
Primary tabs
Contacts
Ranahnah Afriye
country director
rafriye@pactworld.org
phone 27.12.754.1440
menlyn woods office park, building a
ground floor, 291 sprite avenue, faerie glen, pretoria, 1440
Jacquie Stone
program manager
jstone@pactworld.org
Capacity Building Support to EpiC Local Partners
Meeting Targets and Maintaining Epidemic Control (EpiC), a five-year global project funded by the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) and the U.S. Agency for International Development (USAID), is dedicated to achieving and maintaining HIV epidemic control. The project provides strategic technical assistance and direct service delivery to break through barriers to 95-95-95 and promote self-reliant management of national HIV programs by improving HIV case-finding, prevention and treatment programming. EpiC is led by FHI 360, with Pact providing capacity building support to local partners.
Advancing Rights in Southern Africa (ARISA)
Every single person has the right to be free from discrimination and attack, and to recourse if their rights are violated. But this remains a dream for many people and communities. The Advancing Rights in Southern Africa project, or ARISA, promotes and protects human rights, especially the rights of the most vulnerable people. ARISA aims to improve recognition, awareness and enforcement of human rights across the Southern African Development Community region. Implemented by a consortium of four organizations including Pact, ARISA is working to create an enabling environment for the promotion and protection of human rights, and to strengthen the capacity and engagement of regional and local civil society actors to seek redress for rights violations.
Government Capacity Building Support
Pact is helping to build the capacity of South Africa's Department of Social Development to better support orphans and vulnerable children, including those affected by abuse, neglect or exploitation. Specifically, the project is strengthening the department's response to tuberculosis, HIV and other diseases among vulnerable children.